UiPath (NYSE:PATH - Get Free Report) will likely be posting its Q2 2027 results after the market closes on Thursday, September 3rd. Analysts expect UiPath to announce earnings of $0.1482 per share and revenue of $397.7660 million for the quarter. Interested persons may review the information on the company's upcoming Q2 2027 earning report for the latest details on the call scheduled for Thursday, September 3, 2026 at 5:00 PM ET.
UiPath (NYSE:PATH - Get Free Report) last announced its quarterly earnings data on Thursday, May 28th. The company reported $0.15 EPS for the quarter, meeting analysts' consensus estimates of $0.15. The company had revenue of $418.38 million for the quarter, compared to the consensus estimate of $397.54 million. UiPath had a net margin of 19.58% and a return on equity of 7.92%. The company's quarterly revenue was up 17.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.11 EPS. On average, analysts expect UiPath to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
UiPath Trading Up 1.0%
UiPath stock opened at $16.83 on Thursday. The company has a fifty day simple moving average of $12.86 and a 200-day simple moving average of $11.66. The stock has a market cap of $8.72 billion, a P/E ratio of 28.05, a price-to-earnings-growth ratio of 2.00 and a beta of 0.96. UiPath has a 12-month low of $9.20 and a 12-month high of $19.84.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on PATH shares. UBS Group cut their price target on UiPath from $13.00 to $12.00 and set a "neutral" rating on the stock in a research note on Monday, June 29th. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of UiPath in a research report on Friday, July 10th. BMO Capital Markets dropped their price objective on UiPath from $14.00 to $13.00 and set a "market perform" rating on the stock in a report on Monday, June 1st. Morgan Stanley decreased their target price on UiPath from $17.00 to $15.00 and set an "equal weight" rating for the company in a research note on Friday, May 29th. Finally, Wall Street Zen lowered shares of UiPath from a "buy" rating to a "hold" rating in a research note on Saturday, May 30th. Two research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and an average price target of $13.87.
Check Out Our Latest Stock Report on PATH
Insider Buying and Selling
In related news, CEO Daniel Dines sold 1,402,347 shares of the company's stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $16.07, for a total value of $22,535,716.29. Following the completion of the sale, the chief executive officer owned 26,491,238 shares in the company, valued at $425,714,194.66. This represents a 5.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 22.44% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On UiPath
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Royal Bank of Canada grew its holdings in shares of UiPath by 8.4% during the first quarter. Royal Bank of Canada now owns 140,774 shares of the company's stock worth $1,450,000 after buying an additional 10,872 shares during the last quarter. Woodline Partners LP raised its stake in UiPath by 69.6% during the 1st quarter. Woodline Partners LP now owns 22,566 shares of the company's stock valued at $232,000 after acquiring an additional 9,257 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in UiPath by 5.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,477,730 shares of the company's stock worth $15,221,000 after acquiring an additional 75,737 shares during the period. Sivia Capital Partners LLC acquired a new stake in UiPath during the 2nd quarter worth approximately $169,000. Finally, Prudential Financial Inc. grew its stake in shares of UiPath by 90.1% in the 2nd quarter. Prudential Financial Inc. now owns 34,029 shares of the company's stock valued at $436,000 after purchasing an additional 16,125 shares during the last quarter. 62.50% of the stock is owned by hedge funds and other institutional investors.
UiPath Company Profile
(
Get Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.